Platelet counts as a biomarker in ANCA-associated vasculitis

被引:44
作者
Willeke, P. [1 ]
Kuempers, P. [1 ]
Schlueter, B. [2 ]
Limani, A. [1 ]
Becker, H. [1 ]
Schotte, H. [1 ]
机构
[1] Univ Hosp Munster, Sect Rheumatol & Clin Immunol, Dept Med D, D-48149 Munster, Germany
[2] Univ Hosp Munster, Ctr Lab Med, D-48149 Munster, Germany
关键词
DISEASE; THROMBOCYTOSIS; THROMBOPOIETIN; INFLAMMATION; PROCALCITONIN; MARKERS; INJURY; CD40L;
D O I
10.3109/03009742.2015.1006247
中图分类号
R5 [内科学];
学科分类号
1002 ; 100201 ;
摘要
Objectives: To determine whether platelet (PLT) counts might serve as a biomarker to distinguish between active anti-neutrophil cytoplasmic antibody (ANCA)-associated vasculitis (AAV) and remission and also between active disease and systemic infection. Method: PLTs were analysed before treatment in patients with AAV in the active state and in remission. PLTs were also analysed in AAV patients with acute infections. The results were correlated with clinical manifestations, the Birmingham Vasculitis Activity Score version 3 [BVAS(v.3)], and other laboratory findings [i.e. C-reactive protein (CRP), leucocytes, differential count, procalcitonin (PCT)]. Diagnostic accuracy was calculated with a receiver operating characteristic (ROC) curve. Results: PLT counts were significantly increased in 98 patients with AAV during the active disease state [median: 405 PLTs/nL; interquartile range (IQR) 288-504] compared to patients in remission (246 PLT/nL; IQR 214-289) (p < 0.001). We found a correlation of PLT counts in active disease with the BVAS(v.3) (r = 0.582, p < 0.001). In AAV patients with systemic infections (n = 37), PLT counts exhibited significantly lower values (226 PLT/nL; IQR 163-273) compared to patients with active disease (p < 0.001). In the ROC curve analysis, the area under the curve (AUC) of PLTs was significantly larger when distinguishing active disease from systemic infection (AUC 0.868) compared to leucocytes (AUC 0.590), CRP (AUC 0.522), or procalcitonin (AUC 0.515) (p < 0.001). Conclusions: PLT counts were found to correlate with disease activity in AAV and thus may be used to represent immunological activity. In addition, PLT counts serve as a marker that can distinguish acute infection from active disease.
引用
收藏
页码:302 / 308
页数:7
相关论文
共 29 条
[1]   Platelet-derived CD40L -: The switch-hitting player of cardiovascular disease [J].
André, P ;
Nannizzi-Alaimo, L ;
Prasad, SK ;
Phillips, DR .
CIRCULATION, 2002, 106 (08) :896-899
[2]  
BEAN RHD, 1965, BIBL HAEMATOL, P43
[3]   Procalcitonin for discrimination between activity of systemic autoimmune disease and systemic bacterial infection [J].
Brunkhorst, R ;
Eberhardt, OK ;
Haubitz, M ;
Brunkhorst, FM .
INTENSIVE CARE MEDICINE, 2000, 26 :S199-S201
[4]   Thrombopoietin is not uniquely responsible for thrombocytosis in inflammatory disorders [J].
Ceresa, Iride F. ;
Noris, Patrizia ;
Ambaglio, Chiara ;
Pecci, Alessandro ;
Balduini, Carlo L. .
PLATELETS, 2007, 18 (08) :579-582
[5]   Circulating thrombopoietin in reactive conditions behaves like an acute phase reactant [J].
Cerutti, A ;
Custodi, P ;
Duranti, M ;
Cazzola, M ;
Balduini, CL .
CLINICAL AND LABORATORY HAEMATOLOGY, 1999, 21 (04) :271-275
[6]   Community-Acquired Pneumonia Diagnostic vs Prognostic Significance of the Platelet Count [J].
Cunha, Burke A. ;
Hage, Jean E. .
CHEST, 2011, 139 (05) :1255-1256
[7]   Platelet soluble CD40L and matrix metalloproteinase 9 activity are proinflammatory mediators in Behcet disease patients [J].
Fernandez Bello, Ihosvany ;
Alvarez, Maria T. ;
Lopez-Longo, Francisco J. ;
Arias-Salgado, Elena G. ;
Martin, Monica ;
Jimenez-Yuste, Victor ;
Rodriguez de la Rua, Ana ;
Butta, Nora V. .
THROMBOSIS AND HAEMOSTASIS, 2012, 107 (01) :88-98
[8]   MAL/SRF complex is involved in platelet formation and megakaryocyte migration by regulating MYL9 (MLC2) and MMP9 [J].
Gilles, Laure ;
Bluteau, Dominique ;
Boukour, Siham ;
Chang, Yunhua ;
Zhang, Yanyan ;
Robert, Thomas ;
Dessen, Philippe ;
Debili, Najet ;
Bernard, Olivier A. ;
Vainchenker, William ;
Raslova, Hana .
BLOOD, 2009, 114 (19) :4221-4232
[9]   Giant cell arteritis - Laboratory tests at the time of diagnosis in a series of 240 patients [J].
Gonzalez-Gay, MA ;
Lopez-Diaz, MJ ;
Barros, S ;
Garcia-Porrua, C ;
Sanchez-Andrade, A ;
Paz-Carreira, J ;
Martin, J ;
Llorca, J .
MEDICINE, 2005, 84 (05) :277-290
[10]   EULAR recommendations for conducting clinical studies and/or clinical trials in systemic vasculitis: focus on anti-neutrophil cytoplasm antibody-associated vasculitis [J].
Hellmich, Bernhard ;
Flossmann, Oliver ;
Gross, Wolfgang L. ;
Bacon, Paul ;
Cohen-Tervaert, Jan Willem ;
Guillevin, Loic ;
Jayne, David ;
Mahr, Alfred ;
Merkel, Peter A. ;
Raspe, Heiner ;
Scott, David G. I. ;
Witter, James ;
Yazici, Hasan ;
Luqmani, Raashid A. .
ANNALS OF THE RHEUMATIC DISEASES, 2007, 66 (05) :605-617